Updates are available Correction dated 2024-02-14
Click to view Correction: https://doi.org/10.1038/s41419-024-06519-7
-
Authors
Danlos, François-Xavier
Grajeda-Iglesias, Claudia
Durand, Sylvère
Sauvat, Allan
Roumier, Mathilde
Cantin, Delphine
Colomba, Emeline
Rohmer, Julien
Pommeret, Fanny
Baciarello, Giulia
Willekens, Christophe
Vasse, Marc
Griscelli, Frank
Fahrner, Jean-Eudes
Goubet, Anne-Gaëlle
Dubuisson, Agathe http://orcid.org/0000-0002-7526-0769
Derosa, Lisa
Nirmalathasan, Nitharsshini
Bredel, Delphine
Mouraud, Séverine
Pradon, Caroline
Stoclin, Annabelle
Rozenberg, Flore
Duchemin, Jérôme
Jourdi, Georges
Ellouze, Syrine
Levavasseur, Françoise
Albigès, Laurence
Soria, Jean-Charles
Barlesi, Fabrice
Solary, Eric http://orcid.org/0000-0002-8629-1341
André, Fabrice
Pène, Frédéric
Ackerman, Félix
Mouthon, Luc
Zitvogel, Laurence http://orcid.org/0000-0003-1596-0998
Marabelle, Aurélien http://orcid.org/0000-0002-5816-3019
Michot, Jean-Marie
Fontenay, Michaela
Kroemer, Guido
- License Information
-
More Information
Article History
Received: 24 November 2020
Revised: 9 February 2021
Accepted: 10 February 2021
First Online: 11 March 2021
Change Date: 14 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41419-024-06519-7
Conflict of interest
: G.K. has been holding research contracts with Bayer Healthcare, Daiichi Sankyo, Genentech, Glaxo Smyth Kline, Institut Mérieux, Kaleido, Lytix Pharma, Nucana, Oncolinx, PharmaMar, Samsara, Sotio, and Vasculox. G.K. is on the Board of Directors of the Bristol Myers Squibb Foundation France. G.K. is a scientific co-founder of everImmune, Samsara Therapeutics, and Therafast Bio. L.Z. is a founder of everImmune.
: The non-interventional study was approved by institutional review boards (IRB) of Cochin-Port Royal (Paris, France) hospital and the ethical committee of Cochin-Port Royal Hospital (CLEP Decision N: AAA-2020-08023). The interventional study was approved by the Foch IRB (approval number IRB00012437) and was registered on the National Institute of Health data platform INDS (n°4710280420). They were conformed to the principles outlined in the Declaration of Helsinki.
